JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BUSH, M. T.
Right arrow Articles by LAMSON, P. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by BUSH, M. T.
Right arrow Articles by LAMSON, P. D.
Journal of Pharmacology And Experimental Therapeutics, Vol. 76, Issue 1, 44-49, 1942
Copyright © 1942 by American Society for Pharmacology and Experimental Therapeutics


STABLE ANESTHETIC SOLUTIONS OF BARBITURIC ACIDS

MILTON T. BUSH 1, H. L. DICKISON 1, and PAUL D. LAMSON 1

1 From the Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee

We have found a number of solvents which seem to be suitable for the administration of the water-insoluble acid-form of certain barbituric acid derivatives. The most versatile of these solvents are paraldehyde and triacetin. Because we do not know the pharmacology of triacetin, we have concentrated our present studies on solutions in paraldehyde.

A 30% solution in paraldehyde of 5-allyl-5-(1-methylbutyl)-barbituric acid seems suitable for the production of any desired degree of hypnosis or anesthesia by intramuscular or intravenous injection. This solution has these advantages over the commonly used aqueous alkaline solutions of barbituric acids: it can be sterilized by heat and remains stable for a long time; it is so slightly irritating that anesthetic doses can be injected intramuscularly without discomfort; the anesthetic dose is contained in a relatively small volume.

For intravenous injection it is possible that corresponding solutions of 1-methyl-5-allyl-5-isopropyl-barbituric acid (narconumal) and of 1-methyl-5-ethyl-5-(1-methylbutyl)-barbituric acid would also be suitable for the production of relatively short anesthesia, to be lengthened if desired by supplemental injections.

Submitted on May 22, 1942







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1942 by the American Society for Pharmacology and Experimental Therapeutics.